Effect of a sustained release formulation of diltiazem on the development of atherosclerosis in cholesterol-fed rabbits
- 1 June 1987
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 65 (3) , 199-205
- https://doi.org/10.1016/0021-9150(87)90035-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Atherosclerosis, calcium, and calcium antagonists.Circulation, 1985
- Calcium entry blocking drugs: Mechanisms of action, experimental studies and clinical usesCurrent Problems in Cardiology, 1985
- Pharmacology of calcium antagonistsThe American Journal of Cardiology, 1985
- Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbitThe American Journal of Cardiology, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984
- Atherosclerosis regression in animal models: Current concepts of cellular and biochemical mechanismsProgress in Cardiovascular Diseases, 1983
- “Calcium-antagonists” and antherosclerosis — basic studies and therapeutic implicationsLife Sciences, 1983
- Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: Report of a cooperative clinical trialThe American Journal of Cardiology, 1982
- Pharmacokinetics of diltiazem in selected animal species and human beingsThe American Journal of Cardiology, 1982
- Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazemThe American Journal of Cardiology, 1980